Europlasma and P2i Settle Lawsuit in USA

26/8/2015.
On March 17, 2015, Europlasma and P2i resolved their dispute in the United States District Court for the Central District of California, Santa Ana Division without any admission or concession of wrongdoing or liability on the part of either Europlasma or P2i.

Europlasma does not and has not infringed the U.S. Reissue Patent No. RE43,651 Patent.

Europlasma ’s non-pulsed plasma technology does not and has not infringed the U.S. Reissue Patent No. RE43,651 Patent.
Please subscribe to our newsletter.

We use cookies to ensure that we give you the best experience on our website. This includes cookies from third-party websites of social media when you visit a page that contains embedded content from social media. Such third-party cookies may follow your use of this website. If you continue to use this website, we assume that you will receive all cookies on this website. However, you can change your cookie settings at any time by deleting your cookies for this domain.